Moore Capital Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-40,000
| Closed | -$812K | – | 512 |
|
|
2023
Q2 | $812K | Buy |
+40,000
| New | +$812K | 0.01% | 285 |
|
|
2021
Q3 | – | Sell |
-25,000
| Closed | -$687K | – | 839 |
|
|
2021
Q2 | $687K | Hold |
25,000
| – | – | 0.01% | 525 |
|
|
2021
Q1 | $702K | Sell |
25,000
-10,000
| -29% | -$281K | 0.01% | 509 |
|
|
2020
Q4 | $909K | Hold |
35,000
| – | – | 0.01% | 398 |
|
|
2020
Q3 | $600K | Hold |
35,000
| – | – | 0.01% | 291 |
|
|
2020
Q2 | $866K | Buy |
+35,000
| New | +$866K | 0.02% | 200 |
|